These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
583 related items for PubMed ID: 24697345
1. Randomized controlled trial on the efficacy of bladder training before removing the indwelling urinary catheter in patients with acute urinary retention associated with benign prostatic hyperplasia. Zhengyong Y, Changxiao H, Shibing Y, Caiwen W. Scand J Urol; 2014 Aug; 48(4):400-4. PubMed ID: 24697345 [Abstract] [Full Text] [Related]
2. The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia. Desgrandchamps F, De La Taille A, Doublet JD, RetenFrance Study Group. BJU Int; 2006 Apr; 97(4):727-33. PubMed ID: 16536763 [Abstract] [Full Text] [Related]
3. Factors predicting the success of a trial without catheter in acute urinary retention secondary to benign prostatic hyperplasia. Bhomi KK, Bhattachan CL. Nepal Med Coll J; 2011 Sep; 13(3):178-81. PubMed ID: 22808810 [Abstract] [Full Text] [Related]
4. Alfuzosin 10 mg once daily increases the chances of successful trial without catheter after acute urinary retention secondary to benign prostate hyperplasia. Tiong HY, Tibung MJ, Macalalag M, Li MK, Consigliere D. Urol Int; 2009 Sep; 83(1):44-8. PubMed ID: 19641358 [Abstract] [Full Text] [Related]
5. The Reten-World survey of the management of acute urinary retention: preliminary results. Emberton M, Fitzpatrick JM. BJU Int; 2008 Mar; 101 Suppl 3():27-32. PubMed ID: 18307683 [Abstract] [Full Text] [Related]
6. Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia. Fitzpatrick JM, Desgrandchamps F, Adjali K, Gomez Guerra L, Hong SJ, El Khalid S, Ratana-Olarn K, Reten-World Study Group. BJU Int; 2012 Jan; 109(1):88-95. PubMed ID: 22117624 [Abstract] [Full Text] [Related]
7. The efficacy of in-and-out catheterization as a way of trial without catheterization strategy for treatment of acute urinary retention induced by benign prostate hyperplasia: variables predicting success outcome. Ko YH, Kim JW, Kang SG, Jang HA, Kang SH, Park HS, Moon du G, Cheon J, Kim JJ, Lee JG. Neurourol Urodyn; 2012 Apr; 31(4):460-4. PubMed ID: 22331691 [Abstract] [Full Text] [Related]
11. Retrospective analysis of management of patients presenting with acute urinary retention due to benign prostatic hyperplasia: a hospital based study. Pandit RK, Agrawal CS, Chalise PR, Sapkota G. Kathmandu Univ Med J (KUMJ); 2008 Apr; 6(24):448-52. PubMed ID: 19483424 [Abstract] [Full Text] [Related]
15. Role of combined use of ketoconazole and tamsulosin in management of acute urinary retention due to benign prostatic obstruction (a randomized controlled trial). Elbendary M, El-Gamal OM, Soliman MG, Tawfik A, Taha MR. Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):362-6. PubMed ID: 24018711 [Abstract] [Full Text] [Related]
16. Efficacy of doxazosin in the treatment of acute urinary retention due to benign prostate hyperplasia. Prieto L, Romero J, López C, Ortiz M, Pacheco JJ. Urol Int; 2008 Dec; 81(1):66-71. PubMed ID: 18645274 [Abstract] [Full Text] [Related]
18. A comparative study on the use of tamsulosin versus alfuzosin in spontaneous micturition recovery after transurethral catheter removal in patients with benign prostatic growth. Maldonado-Ávila M, Manzanilla-García HA, Sierra-Ramírez JA, Carrillo-Ruiz JD, González-Valle JC, Rosas-Nava E, Guzman-Esquivel J, Labra-Salgado IR. Int Urol Nephrol; 2014 Apr; 46(4):687-90. PubMed ID: 24061764 [Abstract] [Full Text] [Related]
19. Benign prostatic hyperplasia: mode of presentation and postoperative outcome. Khan M, Khan AL, Khan S, Nawaz H. J Pak Med Assoc; 2005 Jan; 55(1):20-3. PubMed ID: 15816691 [Abstract] [Full Text] [Related]